AIM-listed Woodford dog Netscientific (NSCI) has announced the departure of its CEO, Francois Martelet as from 30 April 2019 – just a few day’s time – in order to assist the Company in reducing its central costs and pursue other career opportunities. Well I daresay not having to pay his salary, bonuses and medical insurance will help a little with the company’s forthcoming cashflow difficulties, but if he is departing to help the company why is this all in accordance with the terms of his service agreement?
PDS Biotechnology (PDSB) joined Nasdaq just over a month ago following the merger of AIM-listed Netscientific (NSCI) investee PDS and previously Nasdaq-listed Edge Therapeutics. Netscientific – itself an investee of Neil Woodford - proudly told the market the listing was at $10 per share, but by the time the RNS came the following morning, the shares had already collapsed to $8.51.
Neil Woodford dog, AIM-listed Netscientific (NSCI) seems to have been forced to put out a statement over its investee PDS which merged with Nasdaq-listed Edge Therapeutics (EDGE) and the combined entity is now listed as PDS Biotechnology (PDSB).
NetScientific (NSCI), the AIM casino listed investment dog backed by Neil Woodford, says that it notes its recent share price movement and confirms that it is not aware of any reason for such movement. It then goes onto to try and spoof any mug punters still reading..
Previously writing on NetScientific (NSCI) it was “Conclusion of Strategic Review” does indeed look more Neil Woodford disaster vicar – including that “the board has concluded that it is in the best interests of the company and its shareholders as a whole to cancel the admission of the ordinary shares to trading on AIM, re-register the company as a private limited company”. There’s now been updates on the General Meeting…
Writing last month on NetScientific (NSCI), it was zero potential offerors; more Neil Woodford disaster vicar? – that following an announcement that, despite having stated it was undertaking a strategic review as “the board believes that the market is undervaluing NetScientific's portfolio”, it continued to not be in receipt of any approaches and, “not aware of any parties who might now make such an approach or initiate such discussions… the company confirms that it has closed the formal sale process”. Now a “Conclusion of Strategic Review” announcement…
An intra-day (11:08am) announcement and Woodford Investment Management the major shareholder. What’s the chances this announcement from self-styled “transatlantic healthcare IP commercialisation group”, NetScientific (NSCI) ain’t going to be good…
There were two enormous red flags waving at NetScientific (NSCI), the healthcare IP commercialisation group. The first was the announcement a few weeks ago of a “strategic review” which in plain English means “we are fucked” and the second was that Britain’s worst performing fund manager Neil “Nomates” Woodford owns 47% of the company with the funds he used to manage round at Invesco owning another 19%. And so to today’s disastrous news.
Search ShareProphets |
Recent Comments |